XML 26 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jul. 31, 2019
Jul. 31, 2018
Cash flows provided by operating activities:    
Net income (loss) $ 173,103 $ (408,667)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation of equipment, building, furniture and fixtures, and amortization of leasehold improvements 65,071 63,104
Share-based compensation costs 44,446 38,896
Amortization of intangible assets 26,610 18,196
Deferred taxes 35,949 491,863
Provision for inventory excess and obsolescence 18,833 19,942
Provision for warranty 15,933 15,715
Other 743 18,164
Changes in assets and liabilities:    
Accounts receivable (2,517) (112,696)
Inventories (115,427) 17,751
Prepaid expenses and other (85,039) (11,163)
Accounts payable, accruals and other obligations (9,005) 14,840
Deferred revenue 4,427 (4,710)
Net cash provided by operating activities 173,127 161,235
Cash flows provided by (used in) investing activities:    
Payments for equipment, furniture, fixtures and intellectual property (49,063) (50,386)
Purchase of available for sale securities (127,601) (217,715)
Proceeds from maturities of available for sale securities 120,000 290,000
Proceeds from sales of available for sale securities 98,263 0
Settlement of foreign currency forward contracts, net (3,155) 4,759
Acquisition of business, net of cash acquired 0 (40,412)
Purchase of equity investment (2,667) (1,433)
Net cash provided by (used in) investing activities 35,777 (15,187)
Cash flows used in financing activities:    
Payment of long-term debt (5,250) (3,000)
Payment of capital lease obligations (2,599) (2,811)
Payment for debt conversion liability (111,268) 0
Shares repurchased for tax withholdings on vesting of stock unit awards (23,234) 0
Repurchases of common stock - repurchase program (110,484) (73,512)
Proceeds from issuance of common stock 22,895 22,735
Net cash used in financing activities (229,940) (56,588)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 392 (3,759)
Net increase (decrease) in cash, cash equivalents and restricted cash (20,644) 85,701
Cash, cash equivalents and restricted cash at beginning of period 745,434 640,513
Cash, cash equivalents and restricted cash at end of period 724,790 726,214
Supplemental disclosure of cash flow information    
Cash paid during the period for interest 29,921 31,561
Cash paid during the period for income taxes, net 21,573 20,099
Non-cash investing activities    
Purchase of equipment in accounts payable 4,328 5,677
Non-cash financing activities    
Repurchase of common stock in accrued liabilities from repurchase program 1,441 1,275
Conversion of debt conversion liability into 1,585,140 shares of common stock $ 52,944 $ 0